Non-small cell lung cancer

You have access
Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma
SHIN ITO, KYOJI TSURUMI, NORIHISA SHINDO, SATOSHI SOMA, KAZUNORI YAMAGUCHI, KEIICHI TAMAI, MAI MOCHIZUKI, HARUNA FUJIMORI, MAMI MORITA, KANA WATANABE, AYA SUZUKI, TATSURO FUKUHARA and JUN YASUDA

Anticancer Research November 2023, 43 (11) 5031-5040; DOI: https://doi.org/10.21873/anticanres.16702
You have access
Impact of Chronic Obstructive Pulmonary Disease on the Long-term Prognosis of Patients Undergoing Lobectomy for Non-small-cell Lung Cancer: A Propensity Score-matched Analysis
KYOTO MATSUDO, TOMOYOSHI TAKENAKA, ASATO HASHINOKUCHI, TAICHI NAGANO, FUMIHIKO KINOSHITA, SHINKICHI TAKAMORI, TAKAKI AKAMINE, MIKIHIRO KOHNO, NAOKO MIURA and TOMOHARU YOSHIZUMI

Anticancer Research November 2023, 43 (11) 5215-5222; DOI: https://doi.org/10.21873/anticanres.16723
You have access
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression
HIROAKI NAGAMINE, MASAKAZU YASHIRO, NAOKI YOSHIMOTO, MOTOHIRO IZUMI, AKIRA SUGIMOTO, KENJI NAKAHAMA, KOICHI OGAWA, YOSHIYA MATSUMOTO, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, KAZUHIRO YAMADA, TETSUYA WATANABE, KAZUHISA AASAI, KAZUHIRO FUKUMURA, AKILA MAYEDA and TOMOYA KAWAGUCHI

Anticancer Research October 2023, 43 (10) 4663-4672; DOI: https://doi.org/10.21873/anticanres.16662
You have access
Prognostic Impact of Central Nervous System Recurrence After Surgery in Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer
TATSURO OKAMOTO, TOMOYOSHI TAKENAKA, KOJI YAMAZAKI, MOTOHARU HAMATAKE, NAOKO MIURA, MITSUHIRO TAKENOYAMA, TAKURO KOMETANI, HITOSHI UEDA, HIDENORI KOUSO and TOKUJIRO YANO

Anticancer Research August 2023, 43 (8) 3543-3551; DOI: https://doi.org/10.21873/anticanres.16532
You have access
Dual Biomarker Combining DNA Damage Repair Gene Mutations and PD-L1 Expression for Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
HYERA KIM, DONG HYUN LIM, YONG SHIK KWON, MI AE KIM and KEON UK PARK

Anticancer Research May 2023, 43 (5) 2343-2349; DOI: https://doi.org/10.21873/anticanres.16399
Open Access
Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer
MASATOSHI NAKAMURA, HITOSHI ISHIKAWA, KAYOKO OHNISHI, KEIICHIRO BABA, TAISUKE SUMIYA, MOTOHIRO MURAKAMI, YUICHI HIROSHIMA, MASASHI MIZUMOTO, TOSHIYUKI OKUMURA and HIDEYUKI SAKURAI

Anticancer Research May 2023, 43 (5) 2003-2013; DOI: https://doi.org/10.21873/anticanres.16361
You have access
Association of STAT3, CYP3A5, and ABCG2 Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients
MASAAKI TANDA, KAZUHIRO YAMAMOTO, TOMOKI HORI, HIROKI NISHIGUCHI, MIKI YAGI, MICHIKO SHIMIZU, TORU KONISHI, TOMONORI OZAKI, NATSUE YOSHIOKA, MOTOKO TACHIHARA, TAKEFUMI ITO, SHIGEKI IKUSHIMA, TOMOHIRO OMURA and IKUKO YANO

Anticancer Research April 2023, 43 (4) 1775-1783; DOI: https://doi.org/10.21873/anticanres.16331
You have access
Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
AKIHIRO TAMIYA, MOTOHIRO TAMIYA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, YOSHINOBU MATSUDA, TAKAHISA KAWAMURA, KEI KUNIMASA, TAKAKO INOUE, KAZUMI NISHINO and KYOICHI OKISHIO

Anticancer Research March 2023, 43 (3) 1325-1330; DOI: https://doi.org/10.21873/anticanres.16280
Open Access
Lung Cancer – Standard Therapy and the Use of a Novel, Highly Effective, Well Tolerated, Treatment With Progesterone Receptor Modulators
JEROME H. CHECK, TRINA PORETTA, DIANE CHECK and MAYA SRIVASTAVA

Anticancer Research March 2023, 43 (3) 951-965; DOI: https://doi.org/10.21873/anticanres.16240
Open Access
Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
MIZUKI YAMAZAKI, NAO KOMIZO, HIROTOSHI IIHARA, CHIEMI HIROSE, KOMEI YANASE, YUTO YAMADA, JUNKI ENDO, SHUJI YAMASHITA, YASUSHI OHNO, KENICHIRO TODOROKI, AKIO SUZUKI and HIDEKI HAYASHI

Anticancer Research February 2023, 43 (2) 725-732; DOI: https://doi.org/10.21873/anticanres.16211

Main menu

User menu

Search

Non-small cell lung cancer

Pages